Eosinophilic fasciitis
Inflammatory disease affecting fascia, often self-limited.
Eosinophilic fasciitis, also called Shulman's syndrome or diffuse fasciitis with eosinophilia, is an inflammatory disease targeting the fascia, along with nearby connective tissues, muscles, blood vessels, and nerves. First described by Shulman in 1974, experts still debate whether it is a distinct illness or a variation of another syndrome. Unlike many forms of fasciitis, it usually resolves on its own and stays limited to the arms and legs, though corticosteroids may be needed, and some cases are linked to aplastic anemia.
This condition is very rare, with roughly 100 reported cases. Onset typically occurs between ages 20 and 60, though children can also be affected. It is slightly more common in men than women, at a ratio of about 1.5 to 1, but more research is needed.
Most cases have no clear cause, but some are tied to strenuous exercise, starting hemodialysis, infection with *Borrelia burgdorferi*, certain medications (such as statins, phenytoin, ramipril, and subcutaneous heparin), other autoimmune diseases (like systemic sclerosis, lupus, and Sjögren syndrome), or blood disorders (including aplastic anemia, multiple myeloma, chronic lymphocytic leukemia, and other leukemias or lymphomas).
Because the disease is rare and symptoms vary, a clear symptom set is hard to pin down. Main signs include pain and swelling in the lower arms and legs, often starting with symmetrical swelling, skin thickening, pain, and redness. Hands and feet are usually spared. As it progresses, the skin may pucker, giving an "orange peel" look. Fever and general fatigue can occur, along with skin fibrosis, joint pain, and secondary carpal tunnel syndrome from median nerve compression.
Diagnosis first rules out similar autoimmune diseases like systemic sclerosis. Key clues are skin changes plus eosinophilia, but the most accurate test is a biopsy of skin, fascia, and muscle. The major criterion is symmetrical, plate-like sclerotic lesions on the distal limbs, without Raynaud phenomenon and after excluding systemic sclerosis. Minor criteria include a biopsy showing fibrosis of subcutaneous connective tissue with thickened fascia and eosinophilic infiltration, or MRI showing thickened fascia. A definitive diagnosis requires the major criterion plus at least one minor criterion.
- First characterized by
- Shulman
- Year characterized
- 1974
- Typical age of onset
- 20 to 60 years
- Sex ratio
- 1.5:1 male to female
- Reported cases
- about 100
- Rarity
- very rare
Lore & Background
Eosinophilic fasciitis presents with pain and swelling in the distal extremities, typically the forearms and lower legs, with the hands and feet spared. Initial symptoms include symmetrical swelling and thickening of the skin, associated pain and erythema, and as the disease progresses, the skin may develop an 'orange peel' appearance. Systemic symptoms such as fever and generalized fatigue can also occur, along with fibrosis of the skin, joint pain, and secondary carpal tunnel syndrome.
Reader's Guide
Eosinophilic fasciitis is significant as a rare inflammatory disorder that primarily affects the fascia, with only about 100 reported cases. Its presentation mimics scleroderma or systemic sclerosis, but it differs by affecting deeper fascial layers rather than the dermis and lacking characteristic features such as Raynaud's syndrome, telangiectasias, and visceral changes. The condition is typically self-limited and confined to the arms and legs, though treatment with corticosteroids is often required. Diagnosis relies on excluding other autoimmune diseases, observing skin changes with eosinophilia, and confirming via biopsy of skin, fascia, and muscle. The major diagnostic criterion is symmetrical 'plate-like' sclerotic lesions in the distal extremities without Raynaud phenomenon, with minor criteria including histologic fibrosis and eosinophilic infiltration or MRI showing fascial thickening. First-line treatment is oral corticosteroids tapered over 1–2 years, with second-line options including DMARDs such as hydroxychloroquine or methotrexate. Prognosis is generally good with early treatment if no visceral involvement is present. The condition's etiology remains idiopathic in most cases, though associations with strenuous exercise, hemodialysis, Borrelia burgdorferi infection, certain medications, and other autoimmune or hematologic disorders have been noted.
Did You Know?
- Eosinophilic fasciitis was first characterized by Shulman in 1974.
- It is a very rare disease with only about 100 cases reported.
- The condition is slightly more common in men than women, with a 1.5:1 ratio.
- Some cases are associated with aplastic anemia.
Frequently Asked Questions
Who is Eosinophilic fasciitis?
Eosinophilic fasciitis, also known as Shulman's syndrome or diffuse fasciitis with eosinophilia, is a rare inflammatory disorder that attacks the fascia and the connective tissues, muscles, blood vessels, and nerves around it. It was first described by Shulman in 1974, and specialists still argue over whether it is a standalone illness or merely a variant of a broader fasciitis spectrum.
What are Eosinophilic fasciitis's powers/role?
The condition targets the fascial layer of the arms and legs, triggering inflammation in surrounding connective tissue, muscle, vasculature, and nerves. It typically presents in adults between 20 and 60 years old, with males affected at roughly a 1.5-to-1 ratio over females.
Why is Eosinophilic fasciitis important?
With only about 100 cases reported in the medical literature, it is an extremely rare entity that tests clinicians' ability to separate it from other inflammatory fascial diseases. Its unusual restriction to the extremities and its generally benign, self-resolving course make it a distinctive outlier in the rheumatologic canon.
When did Eosinophilic fasciitis first appear?
The condition was first characterized by Shulman in 1974, and in the nearly five decades since, it has remained a very rare diagnosis with roughly 100 documented cases worldwide.
More in Steroid-responsive inflammatory conditions 1-24
Spotted an error? Know more?
Reader corrections go straight into our review queue. Suggest an edit · How this site is sourced